vs
Apellis Pharmaceuticals, Inc.（APLS）与BARRETT BUSINESS SERVICES INC（BBSI）财务数据对比。点击上方公司名可切换其他公司
BARRETT BUSINESS SERVICES INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$321.1M vs $199.9M），BARRETT BUSINESS SERVICES INC净利率更高（5.1% vs -29.5%，领先34.6%），BARRETT BUSINESS SERVICES INC同比增速更快（5.3% vs -5.9%），BARRETT BUSINESS SERVICES INC自由现金流更多（$70.6M vs $-14.3M），过去两年BARRETT BUSINESS SERVICES INC的营收复合增速更高（9.9% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
巴雷特枪械制造公司是一家由澳大利亚控股的美国枪械弹药制造商，总部位于田纳西州克里斯蒂安娜。公司由罗尼·G·巴雷特于1982年创立，最初的业务是研发适配.50 BMG弹药的半自动步枪，该弹药原本为勃朗宁M2重机枪研发设计，公司推出的首款成品枪械即为M82狙击步枪。
APLS vs BBSI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $321.1M |
| 净利润 | $-59.0M | $16.4M |
| 毛利率 | — | 21.3% |
| 营业利润率 | -25.6% | 5.8% |
| 净利率 | -29.5% | 5.1% |
| 营收同比 | -5.9% | 5.3% |
| 净利润同比 | -62.2% | -2.4% |
| 每股收益（稀释后） | $-0.40 | $0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $321.1M | ||
| Q3 25 | $458.6M | $318.9M | ||
| Q2 25 | $178.5M | $307.7M | ||
| Q1 25 | $166.8M | $292.6M | ||
| Q4 24 | $212.5M | $304.8M | ||
| Q3 24 | $196.8M | $294.3M | ||
| Q2 24 | $199.7M | $279.7M | ||
| Q1 24 | $172.3M | $265.8M |
| Q4 25 | $-59.0M | $16.4M | ||
| Q3 25 | $215.7M | $20.6M | ||
| Q2 25 | $-42.2M | $18.5M | ||
| Q1 25 | $-92.2M | $-1.0M | ||
| Q4 24 | $-36.4M | $16.8M | ||
| Q3 24 | $-57.4M | $19.6M | ||
| Q2 24 | $-37.7M | $16.7M | ||
| Q1 24 | $-66.4M | $-136.0K |
| Q4 25 | — | 21.3% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 23.8% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 25.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 14.9% |
| Q4 25 | -25.6% | 5.8% | ||
| Q3 25 | 48.7% | 7.8% | ||
| Q2 25 | -18.6% | 7.5% | ||
| Q1 25 | -50.0% | -1.4% | ||
| Q4 24 | -12.3% | 6.8% | ||
| Q3 24 | -24.0% | 8.0% | ||
| Q2 24 | -14.7% | 7.3% | ||
| Q1 24 | -36.0% | -1.8% |
| Q4 25 | -29.5% | 5.1% | ||
| Q3 25 | 47.0% | 6.5% | ||
| Q2 25 | -23.6% | 6.0% | ||
| Q1 25 | -55.3% | -0.3% | ||
| Q4 24 | -17.1% | 5.5% | ||
| Q3 24 | -29.2% | 6.7% | ||
| Q2 24 | -18.9% | 6.0% | ||
| Q1 24 | -38.5% | -0.1% |
| Q4 25 | $-0.40 | $0.63 | ||
| Q3 25 | $1.67 | $0.79 | ||
| Q2 25 | $-0.33 | $0.70 | ||
| Q1 25 | $-0.74 | $-0.04 | ||
| Q4 24 | $-0.30 | $0.63 | ||
| Q3 24 | $-0.46 | $0.74 | ||
| Q2 24 | $-0.30 | $0.62 | ||
| Q1 24 | $-0.54 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $157.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $241.0M |
| 总资产 | $1.1B | $779.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $157.2M | ||
| Q3 25 | $479.2M | $109.8M | ||
| Q2 25 | $370.0M | $90.4M | ||
| Q1 25 | $358.4M | $99.1M | ||
| Q4 24 | $411.3M | $121.9M | ||
| Q3 24 | $396.9M | $14.4M | ||
| Q2 24 | $360.1M | $40.3M | ||
| Q1 24 | $325.9M | $51.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
| Q4 25 | $370.1M | $241.0M | ||
| Q3 25 | $401.2M | $240.1M | ||
| Q2 25 | $156.3M | $225.8M | ||
| Q1 25 | $164.2M | $213.4M | ||
| Q4 24 | $228.5M | $221.4M | ||
| Q3 24 | $237.1M | $215.4M | ||
| Q2 24 | $264.3M | $199.0M | ||
| Q1 24 | $266.7M | $189.6M |
| Q4 25 | $1.1B | $779.1M | ||
| Q3 25 | $1.1B | $777.9M | ||
| Q2 25 | $821.4M | $713.6M | ||
| Q1 25 | $807.3M | $778.6M | ||
| Q4 24 | $885.1M | $745.5M | ||
| Q3 24 | $901.9M | $725.8M | ||
| Q2 24 | $904.5M | $688.6M | ||
| Q1 24 | $831.9M | $747.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $76.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $70.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 22.0% |
| 资本支出强度资本支出/营收 | 0.1% | 1.7% |
| 现金转化率经营现金流/净利润 | — | 4.64× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $47.2M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $76.1M | ||
| Q3 25 | $108.5M | $38.4M | ||
| Q2 25 | $4.4M | $-53.8M | ||
| Q1 25 | $-53.4M | $5.2M | ||
| Q4 24 | $19.4M | $53.4M | ||
| Q3 24 | $34.1M | $-935.0K | ||
| Q2 24 | $-8.3M | $-51.3M | ||
| Q1 24 | $-133.0M | $9.0M |
| Q4 25 | $-14.3M | $70.6M | ||
| Q3 25 | $108.3M | $34.1M | ||
| Q2 25 | $4.4M | $-58.2M | ||
| Q1 25 | $-53.4M | $697.0K | ||
| Q4 24 | $19.3M | $50.2M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | $-8.4M | $-56.3M | ||
| Q1 24 | $-133.3M | $6.2M |
| Q4 25 | -7.1% | 22.0% | ||
| Q3 25 | 23.6% | 10.7% | ||
| Q2 25 | 2.5% | -18.9% | ||
| Q1 25 | -32.0% | 0.2% | ||
| Q4 24 | 9.1% | 16.5% | ||
| Q3 24 | — | -1.4% | ||
| Q2 24 | -4.2% | -20.1% | ||
| Q1 24 | -77.3% | 2.3% |
| Q4 25 | 0.1% | 1.7% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.0% | 1.5% | ||
| Q4 24 | 0.0% | 1.0% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.0% | 1.8% | ||
| Q1 24 | 0.2% | 1.0% |
| Q4 25 | — | 4.64× | ||
| Q3 25 | 0.50× | 1.86× | ||
| Q2 25 | — | -2.92× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.18× | ||
| Q3 24 | — | -0.05× | ||
| Q2 24 | — | -3.07× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
BBSI
| Professional Employer Services | $303.6M | 95% |
| Staffing Services | $17.6M | 5% |
